Patent Law | Jotup

Appili Therapeutics Announces Issuance of Patent for ATI-1501 Liquid Oral Reformulation of Metronidazole

Retrieved on:

Wednesday, May 24, 2023

Professional Services, Patent Law, Health, Infectious Diseases, Pharmaceutical, Biotechnology, Patent, Drug development, Pharming, Infection, Prescription, Metronidazole, State, Patient, TSX, FDA, Therapy, Pharmaceutical industry

18/072,154 filed on November 30, 2022 and titled “Oral Formulations of Metronidazole and Methods of Treating an Infection Using Same”.

Key Points:

18/072,154 filed on November 30, 2022 and titled “Oral Formulations of Metronidazole and Methods of Treating an Infection Using Same”.
Metronidazole is a widely used frontline oral treatment with over 10 million prescriptions written in the United States every year to help treat parasitic and anaerobic bacterial infections.
“We believe our liquid oral reformulation solves a significant and growing issue for patients who cannot tolerate the current tablet formulation of metronidazole, especially for the elderly and children who often have difficulty taking solid oral medicines” said Don Cilla, Pharm.D., M.B.A., President and Chief Executive Officer of Appili Therapeutics.
“This patent recognizes innovative research by Appili Therapeutics to fill this significant gap in the treatment paradigm, and further strengthens ATI-1501’s position as a more convenient antibiotic treatment option on the market.

Seoul Semiconductor Obtains Permanent Injunction Against Various LED Products for Patent Infringement in Europe

Retrieved on:

Thursday, May 18, 2023

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED products and technology, announced on May 16 that the Higher Regional Court in Düsseldorf, Germany, issued a final judgement confirming a permanent injunction for infringement of Seoul’s patent against multiple LED companies' LEDs.

Key Points:

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED products and technology, announced on May 16 that the Higher Regional Court in Düsseldorf, Germany, issued a final judgement confirming a permanent injunction for infringement of Seoul’s patent against multiple LED companies' LEDs.
View the full release here: https://www.businesswire.com/news/home/20230518005058/en/
Seoul Semiconductor's patent technology applied to various solutions (Graphic: Seoul Semiconductor Co., Ltd.)
The permanent injunction judgement extends to LED products from Everlight Electronics Co., Ltd., which were distributed globally through Mouser Electronics Inc., as well as LED products from LED Engin merged into Osram GmbH.
Under this new system, patent infringement judgements from the Unified Patent Court will simultaneously take effect in 17 European countries, including Germany, France, and Italy.
As a result, Seoul and its affiliates have obtained 14 permanent injunction judgements against manufacturers and distributors of infringing products in the U.S. and Europe over the past five years.

Hytera Prevails Over Patent Lawsuit Filed by Motorola Solutions

Retrieved on:

Friday, May 5, 2023

Hytera Communications (SZSE: 002583), a leading global provider of professional communication technologies and solutions, today announced that the Court of Appeals Düsseldorf has ruled in favor of Hytera Communications Corporation Limited (Hytera) and its subsidiary HMF Smart Solutions GmbH (HMF) in patent infringement proceedings initiated by Motorola Solutions Inc. (MSI) at the Regional Court Düsseldorf back in 2017 and 2018.

Key Points:

Hytera Communications (SZSE: 002583), a leading global provider of professional communication technologies and solutions, today announced that the Court of Appeals Düsseldorf has ruled in favor of Hytera Communications Corporation Limited (Hytera) and its subsidiary HMF Smart Solutions GmbH (HMF) in patent infringement proceedings initiated by Motorola Solutions Inc. (MSI) at the Regional Court Düsseldorf back in 2017 and 2018.
In 2017, MSI filed a complaint alleging infringement of its European patent EP 2 342 851 B1 by Hytera’s Pseudo-Trunking/TDMA direct mode/TX-none radio functionality.
The complaint was initially filed against HMF (“Hytera Mobilfunk GmbH” back then).
After Hytera joined as an intervener in these proceedings on the side of HMF, MSI extended its complaint against Hytera, resulting in two parallel proceedings.

AHF: EU Should Ditch Patents During Health Crises

Retrieved on:

Tuesday, April 25, 2023

“We applaud the EU for taking action before another health emergency strikes.

Key Points:

“We applaud the EU for taking action before another health emergency strikes.
Getting bogged down in patent disputes during a pandemic leads to lives lost—that’s completely unacceptable regardless of how much big pharma objects,” said AHF Europe Bureau Chief Zoya Shabarova.
“However, EU actions should not be limited to compulsory licensing.
IP rights waivers should become an integral part of a health crisis management toolbox embedded in pharmaceutical legislation, TRIPS revisions, and the upcoming Pandemic Accord.”

Downstreem Announces Pending Patent for the Industry’s First Cloud-Based Mobile Forensics Platform Featuring AI Tools

Retrieved on:

Thursday, April 13, 2023

Legal, Technology, Mobile, Wireless, Patent Law, Telecommunications, Professional Services, Software, Data Analytics, Artificial Intelligence, United States Patent and Trademark Office, ECA, Patent, Facial recognition, Mobile phone

Downstreem , a global digital forensics company specializing in mobile devices and complex forensic analysis, today announces its patent application with the United States Patent and Trademark Office (USPTO) has been accepted for its new mobile forensics product, StreemView.

Key Points:

Downstreem , a global digital forensics company specializing in mobile devices and complex forensic analysis, today announces its patent application with the United States Patent and Trademark Office (USPTO) has been accepted for its new mobile forensics product, StreemView.
The patent-pending platform is the industry’s first cloud-based forensics analysis and investigation solution designed specifically for mobile device data and email.
Launched to the market in March 2023, StreemView offers a mobile device analysis, investigation and culling (ECA) platform that features on-demand AI tools and supports all data types and operating systems from any mobile device, making it the industry’s most comprehensive mobile-first forensics platform.
Built cloud-native, the StreemView platform opens up new mobile forensics opportunities with an easy-to-use interface similar to a mobile app and unique, cutting-edge AI features such as emoji clouds and cross-platform chat threading.”
The pending platform’s on-demand AI tools deliver the most advanced mobile forensics analysis features in the market.

Patented Tax Return Automation Addresses AI Concerns for CPAs

Retrieved on:

Thursday, April 6, 2023

Software, Finance, Patent Law, Artificial Intelligence, Data Management, Accounting, Professional Services, Technology, Fear, Patent, CPA, Invention, AI, Automation, Medical device, EU, Once

Their first patent was issued March 23, 2021, and they now add their second patent issued February 21, 2023.

Key Points:

Their first patent was issued March 23, 2021, and they now add their second patent issued February 21, 2023.
“The public accounting technology field is growing, and many are pursuing ways to automate much of the data processing and even tax filings – and with that comes the fear from many that AI may make the human element of tax advisory services obsolete.”
“For automation built by AI to effectively automate tax preparation like our platform has, the AI would likely have to overlap with what Once does and that process is a patented process.
The Once team refers to their AI as “Accountants Intelligence”, a knowledge-based automation tool that adapts and changes and is based on the expertise of the CPA.
“Our goal as a company is to improve the capabilities of CPAs in advising their clients, not make them obsolete.

Markforged Announces Positive Ruling in Patent Infringement Lawsuit

Retrieved on:

Tuesday, April 4, 2023

Professional Services, Machine Tools, Metalworking & Metallurgy, Patent Law, Manufacturing, Machinery, Steel, District court, Patent, NYSE, Continuity, Markforged

The court ruling confirms that Markforged does not infringe these patents and supports Markforged's position that these claims were meritless.

Key Points:

The court ruling confirms that Markforged does not infringe these patents and supports Markforged's position that these claims were meritless.
Following this ruling, Continuous Composites conceded that the four patents comprising a total of twenty patent claims should be removed from the case.
Currently, only a single, recently-issued patent that was added to the case in February 2022, comprising two patent claims asserted by Continuous Composites, remains.
Markforged maintains its position that it does not infringe this last patent, and will continue to defend against the remaining claims.

Thread Count Sheet Patent Battle Comes to a Close with Judge Dismissing Challenge Against 10 AAVN Patents

Retrieved on:

Wednesday, March 29, 2023

Supply Chain Management, Other Retail, Professional Services, Online Retail, Luxury, Department Stores, Specialty, Patent Law, Other Manufacturing, Textiles, Retail, Home Goods, Manufacturing, Jazz Photo Corp. v. United States International Trade Commission, Winstead, Bed, Patent, United States International Trade Commission, Carbon fibers

The Middle District of North Carolina Court dismissed Globe Cotyarn, Ltd.’s federal complaint seeking to invalidate all 10 of AAVN, Inc.’s patents related to the manufacturing of high thread count textiles—particularly, high thread count cotton rich bed sheets.

Key Points:

The Middle District of North Carolina Court dismissed Globe Cotyarn, Ltd.’s federal complaint seeking to invalidate all 10 of AAVN, Inc.’s patents related to the manufacturing of high thread count textiles—particularly, high thread count cotton rich bed sheets.
As a manufacturer and patent owner under Alpha Cotton® of high thread count fabrics in the U.S., AAVN, Inc., competes with other manufacturers in the bedsheet industry.
The advertised thread count is the “apples to apples” comparison consumers use in differentiating the relative quality of sheet sets.
These patents are the only way that high thread count cotton rich sheets can meet correct thread count standards.

InductEV Successfully Defends Mission-Critical Patents

Retrieved on:

Wednesday, March 29, 2023

EV, Electric Vehicles, Automotive, Patent Law, Automotive Manufacturing, Professional Services, Manufacturing, Other Automotive, Alternative Energy, Energy, Momentum, WiTricity, PTAB, Patent, 3D printing, EU

In recent decisions by the Delaware District Court and the U.S. Patent Trial and Appeal Board ("PTAB"), challenges to six WiTricity patents by InductEV were successful and resulted in the invalidation of those six WiTricity patents.

Key Points:

In recent decisions by the Delaware District Court and the U.S. Patent Trial and Appeal Board ("PTAB"), challenges to six WiTricity patents by InductEV were successful and resulted in the invalidation of those six WiTricity patents.
InductEV designs and manufactures high-power induction charging systems which are already in commercial operation, based on its own commercially proven, patented technologies.
In response to the invalidation of six of its patents, WiTricity has now filed a second lawsuit, and the Company expects to prevail in this new suit.
"At InductEV, we make charging commercial electric vehicles simple, safe, and cost effective.

NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra

Retrieved on:

Tuesday, March 21, 2023

Professional Services, Patent Law, Medical Devices, Health, Health Technology, General Health, Patent, Catheter-associated urinary tract infection, United States Patent and Trademark Office, Patent application, SAWS, JN-International Medical Corporation, Patient, Ultra, CAUTI, Medical imaging

NanoVibronix, Inc ., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced it has filed a new provisional patent application with the United States Patent and Trademark Office (“USPTO”) entitled “Multiple Frequency Surface Acoustic Waves for Internal Medical Device” (the "Patent Application") related to its UroShield.

Key Points:

NanoVibronix, Inc ., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced it has filed a new provisional patent application with the United States Patent and Trademark Office (“USPTO”) entitled “Multiple Frequency Surface Acoustic Waves for Internal Medical Device” (the "Patent Application") related to its UroShield.
The Patent Application covers a recently developed enhancement to the UroShield product, UroShield “Ultra”, which incorporates improvements to the Company’s original UroShield.
The next generation UroShield Ultra includes modified housing that is designed to improve catheter coupling and incorporates multiple actuators that work in sequence to discourage bacterial docking by delivering SAWs at multiple frequencies directly to indwelling catheters.
UroShield has been proven to be instrumental in improving outcomes for hospital patients suffering from CAUTI.